Gastroenterology and Hepatology

Track26:Hepatitis E: Latest Updates and Research

Hepatitis E, caused by the Hepatitis E virus (HEV), is a significant global health issue, primarily transmitted through contaminated water. While often self-limiting, the disease can cause severe complications in pregnant women, immunocompromised patients, and individuals with underlying liver conditions. HEV is gaining attention due to its rising incidence in both developed and developing countries, with emerging reports of genotype 3 and genotype 4 strains in non-endemic regions.

This session will explore the latest research on the epidemiology, molecular mechanisms, and clinical management of Hepatitis E. Key topics will include genetic diversity of HEV, the impact of coinfections with other viruses, and new diagnostic tools.The track will highlight recent advances in vaccine development, as well as antiviral treatments for chronic infections, which remain a challenge due to limited therapeutic options. Researchers will discuss novel drug candidates and immunization strategies to reduce the global burden of HEV.

Attendees will gain a deeper understanding of Hepatitis E, its clinical implications, and the latest advances in diagnosis, treatment, and prevention.